Antibody data
- Antibody Data
- Antigen structure
- References [25]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16791-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#16791-1-AP, RRID:AB_2142051
- Product name
- METTL5 antibody
- Antibody type
- Polyclonal
- Description
- METTL5 antibody (Cat. #16791-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references ZNF460 Promotes the m6A Modification of COPS6 to Facilitate Immune Escape in Colorectal Cancer.
METTL5 promotes fatty acid metabolism by modulating peroxisome to induce hepatocellular carcinoma recurrence after thermal ablation.
The human 18S rRNA m6A methyltransferase METTL5 promotes tumorigenesis via DEPDC1 in lung squamous cell carcinoma.
METTL5 triggers the ferroptosis of cardiomyocytes in sepsis-induced myocardial injury.
IGF2BP3 redirects glycolytic flux to promote one-carbon metabolism and RNA methylation.
Scutellarin suppresses ovarian cancer progression by targeting METTL5.
METTL5 Promotes Tumor Progression in Oral Squamous Cell Carcinoma by Activating the Myc Pathway.
METTL4 and METTL5 as biomarkers for recurrence-free survival in hepatocellular carcinoma patients.
Tumor Intrinsic METTL5 Modulates ATF4 Translation to Prevent T Cell-Induced Ferroptosis in Ovarian Cancer.
METTL5 regulates SEPHS2-mediated selenoprotein synthesis to promote multiple myeloma survival and progression.
METTL5 enhances the mRNA stability of TPRKB through m(6)A modification to facilitate the aggressive phenotypes of hepatocellular carcinoma cell.
METTL5 promotes gastric cancer progression via sphingomyelin metabolism.
BIRC5 facilitates cisplatin-chemoresistance in a m(6)A-dependent manner in ovarian cancer.
The m6A methyltransferase METTL5 promotes neutrophil extracellular trap network release to regulate hepatocellular carcinoma progression.
METTL5 regulates cranial suture fusion via Wnt signaling.
METTL3 regulates breast cancer-associated alternative splicing switches.
N(6)-methyladenosine modification in 18S rRNA promotes tumorigenesis and chemoresistance via HSF4b/HSP90B1/mutant p53 axis.
Loss of m(6)A Methyltransferase METTL5 Promotes Cardiac Hypertrophy Through Epitranscriptomic Control of SUZ12 Expression.
The METTL5-TRMT112 N(6)-methyladenosine methyltransferase complex regulates mRNA translation via 18S rRNA methylation.
The potential role of methyltransferase-like 5 in deficient mismatch repair of uterine corpus endometrial carcinoma.
Long noncoding RNA UBA6-AS1 inhibits the malignancy of ovarian cancer cells via suppressing the decay of UBA6 mRNA.
TWIK-related acid-sensitive K(+) channel 2 promotes renal fibrosis by inducing cell-cycle arrest.
N(6)-methyladenosine (m(6)A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation.
The 18S rRNA m(6) A methyltransferase METTL5 promotes mouse embryonic stem cell differentiation.
Ribosome 18S m(6)A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth.
Lun W, Liu Y, Luo C, Wu H
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2026 Mar 31;40(6):e71640
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2026 Mar 31;40(6):e71640
METTL5 promotes fatty acid metabolism by modulating peroxisome to induce hepatocellular carcinoma recurrence after thermal ablation.
Xie Z, Wang L, Wu Y, Zhang Y, Wang S, Zeng X, Liang R, Long J, Guo J, Peng S, Kuang M, Lin S, Dai Z, Chen S
Molecular therapy : the journal of the American Society of Gene Therapy 2026 Feb 4;34(2):1215-1233
Molecular therapy : the journal of the American Society of Gene Therapy 2026 Feb 4;34(2):1215-1233
The human 18S rRNA m6A methyltransferase METTL5 promotes tumorigenesis via DEPDC1 in lung squamous cell carcinoma.
Yan Y, Fu J
Frontiers in oncology 2025;15:1522157
Frontiers in oncology 2025;15:1522157
METTL5 triggers the ferroptosis of cardiomyocytes in sepsis-induced myocardial injury.
Wang X, Tian Q, Li M, Liu Y
Free radical biology & medicine 2025 Sep;237:1-10
Free radical biology & medicine 2025 Sep;237:1-10
IGF2BP3 redirects glycolytic flux to promote one-carbon metabolism and RNA methylation.
Sharma G, Gutierrez M, Jones AE, Kapoor S, Jaiswal AK, Neeb ZT, Rios A, Dorairaj P, Thaxton ML, Lin TL, Tran TM, Kabbani LES, Ritter AJ, Scherer GM, Sorrentino JP, Stiles L, Hoeve JT, Damoiseaux RD, Garg NK, Divakaruni AS, Sanford JR, Rao DS
Cell reports 2025 Oct 28;44(10):116330
Cell reports 2025 Oct 28;44(10):116330
Scutellarin suppresses ovarian cancer progression by targeting METTL5.
Ding L, Luo C, Weygant N, Chen W, Ru D, Lai Y, Wang Y, Li H
Scientific reports 2025 May 27;15(1):18472
Scientific reports 2025 May 27;15(1):18472
METTL5 Promotes Tumor Progression in Oral Squamous Cell Carcinoma by Activating the Myc Pathway.
Huang R, Feng X, Zhou T, Lu J, Wang Y, Zhang S, Zhang W
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2025 Feb;54(2):91-99
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2025 Feb;54(2):91-99
METTL4 and METTL5 as biomarkers for recurrence-free survival in hepatocellular carcinoma patients.
Zhao J, Sun R, Zhi L, Guo D, Ling S, Liang X, Li J, Jia C
Future oncology (London, England) 2025 Feb;21(3):331-340
Future oncology (London, England) 2025 Feb;21(3):331-340
Tumor Intrinsic METTL5 Modulates ATF4 Translation to Prevent T Cell-Induced Ferroptosis in Ovarian Cancer.
Hou J, Ju CW, Egan NA, Wei Y, Wang Y, Dang M, Zhou T, Shi L, Zheng N, Chen S, Guerrero AM, Liang X, Wu W, Akhtar A, Dhiman C, Roy Burman D, Gerges AE, Flores MD, Li H, Zhang LS, Kok M, Mao X, Wang L, Feng Q, Chen Y, Lee S, McGrail DJ, Sahni N, He C, Jazaeri AA, Peng W
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Dec;12(46):e07718
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2025 Dec;12(46):e07718
METTL5 regulates SEPHS2-mediated selenoprotein synthesis to promote multiple myeloma survival and progression.
Jiang J, Zhong F, Xiao Z, Yao F, Liu J, Li M, Zeng H, Qiu Y, Zhang J, Zhang H, Li S, Huang T, Feng W, Huang Z, Huang B, Wang X
Cell death & disease 2025 Aug 2;16(1):585
Cell death & disease 2025 Aug 2;16(1):585
METTL5 enhances the mRNA stability of TPRKB through m(6)A modification to facilitate the aggressive phenotypes of hepatocellular carcinoma cell.
Luo M, Luo X, Sun J, Ao X, Han H, Yang X
Experimental cell research 2024 Sep 1;442(1):114219
Experimental cell research 2024 Sep 1;442(1):114219
METTL5 promotes gastric cancer progression via sphingomyelin metabolism.
Zhang YQ, Li J, Qin Z, Li DM, Ye FZ, Bei SH, Zhang XH, Feng L
World journal of gastrointestinal oncology 2024 May 15;16(5):1925-1946
World journal of gastrointestinal oncology 2024 May 15;16(5):1925-1946
BIRC5 facilitates cisplatin-chemoresistance in a m(6)A-dependent manner in ovarian cancer.
Fan Y, Pan Y, Jia L, Gu S, Liu B, Mei Z, Lv C, Huang H, Zhu G, Deng Q
Cancer medicine 2024 Jan;13(1):e6811
Cancer medicine 2024 Jan;13(1):e6811
The m6A methyltransferase METTL5 promotes neutrophil extracellular trap network release to regulate hepatocellular carcinoma progression.
Wang Q, Huang Y, Zhu Y, Zhang W, Wang B, Du X, Dai Q, Zhang F, Fang Z
Cancer medicine 2024 Apr;13(7):e7165
Cancer medicine 2024 Apr;13(7):e7165
METTL5 regulates cranial suture fusion via Wnt signaling.
Lei K, Xu R, Wang Q, Xiong Q, Zhou X, Li Q, Seriwatanachai D, Lin S, Zhou C, Yuan Q
Fundamental research 2023 May;3(3):369-376
Fundamental research 2023 May;3(3):369-376
METTL3 regulates breast cancer-associated alternative splicing switches.
Achour C, Bhattarai DP, Groza P, Román ÁC, Aguilo F
Oncogene 2023 Mar;42(12):911-925
Oncogene 2023 Mar;42(12):911-925
N(6)-methyladenosine modification in 18S rRNA promotes tumorigenesis and chemoresistance via HSF4b/HSP90B1/mutant p53 axis.
Chen B, Huang Y, He S, Yu P, Wu L, Peng H
Cell chemical biology 2023 Feb 16;30(2):144-158.e10
Cell chemical biology 2023 Feb 16;30(2):144-158.e10
Loss of m(6)A Methyltransferase METTL5 Promotes Cardiac Hypertrophy Through Epitranscriptomic Control of SUZ12 Expression.
Han Y, Du T, Guo S, Wang L, Dai G, Long T, Xu T, Zhuang X, Liu C, Li S, Zhang D, Liao X, Dong Y, Lui KO, Tan X, Lin S, Chen Y, Huang ZP
Frontiers in cardiovascular medicine 2022;9:852775
Frontiers in cardiovascular medicine 2022;9:852775
The METTL5-TRMT112 N(6)-methyladenosine methyltransferase complex regulates mRNA translation via 18S rRNA methylation.
Sepich-Poore C, Zheng Z, Schmitt E, Wen K, Zhang ZS, Cui XL, Dai Q, Zhu AC, Zhang L, Sanchez Castillo A, Tan H, Peng J, Zhuang X, He C, Nachtergaele S
The Journal of biological chemistry 2022 Mar;298(3):101590
The Journal of biological chemistry 2022 Mar;298(3):101590
The potential role of methyltransferase-like 5 in deficient mismatch repair of uterine corpus endometrial carcinoma.
Liu X, Ma H, Ma L, Li K, Kang Y
Bioengineered 2022 Mar;13(3):5525-5536
Bioengineered 2022 Mar;13(3):5525-5536
Long noncoding RNA UBA6-AS1 inhibits the malignancy of ovarian cancer cells via suppressing the decay of UBA6 mRNA.
Wang Y, Chen Z
Bioengineered 2022 Jan;13(1):178-189
Bioengineered 2022 Jan;13(1):178-189
TWIK-related acid-sensitive K(+) channel 2 promotes renal fibrosis by inducing cell-cycle arrest.
Zhang J, Chen J, Lu Y, Yang Y, Chen W, Shen B, Hu J, Jia P, Xu S, Shi Y, Ning Y, Wang J, Fang Y, Zhao S, Li Y, Dai Y, Zhang X, Xiang M, Tian Y, Liu Z, Song N, Ding X
iScience 2022 Dec 22;25(12):105620
iScience 2022 Dec 22;25(12):105620
N(6)-methyladenosine (m(6)A) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation.
Peng H, Chen B, Wei W, Guo S, Han H, Yang C, Ma J, Wang L, Peng S, Kuang M, Lin S
Nature metabolism 2022 Aug;4(8):1041-1054
Nature metabolism 2022 Aug;4(8):1041-1054
The 18S rRNA m(6) A methyltransferase METTL5 promotes mouse embryonic stem cell differentiation.
Xing M, Liu Q, Mao C, Zeng H, Zhang X, Zhao S, Chen L, Liu M, Shen B, Guo X, Ma H, Chen H, Zhang J
EMBO reports 2020 Oct 5;21(10):e49863
EMBO reports 2020 Oct 5;21(10):e49863
Ribosome 18S m(6)A Methyltransferase METTL5 Promotes Translation Initiation and Breast Cancer Cell Growth.
Rong B, Zhang Q, Wan J, Xing S, Dai R, Li Y, Cai J, Xie J, Song Y, Chen J, Zhang L, Yan G, Zhang W, Gao H, Han JJ, Qu Q, Ma H, Tian Y, Lan F
Cell reports 2020 Dec 22;33(12):108544
Cell reports 2020 Dec 22;33(12):108544
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- PC-3 cells were subjected to SDS PAGE followed by western blot with 16791-1-AP(METTL5 antibody) at dilution of 1:800
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunofluorescent analysis of HepG2 cells, using METTL5 antibody 16791-1-AP at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunohistochemical of paraffin-embedded human brain using 16791-1-AP(METTL5 antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- Immunohistochemical of paraffin-embedded human brain using 16791-1-AP(METTL5 antibody) at dilution of 1:100 (under 40x lens)
- Sample type
- tissue